Page 76 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis

52 David S. Younger

[42] Churg, J., Strauss, L. Allergic granulomatosis, allergic angiitis, and periarteritis nodosa.
Am. J. Pathol. 1951; 27:277-301.

[43] Masi, A. T., Hunder, G. G., Lie, J. T., et al. The American College of Rheumatology
1990 criteria for the classification of Churg-Strauss syndrome (Allergic granulomatosis
and angiitis). Arthritis Rheum. 1990; 33:1094-1100.

[44] Comarmond, C., Pagnoux, C., Khellaf, M., et al., for the French Vasculitis Study
Group. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss). Arthritis Rheum.
2013; 65:270-281.

[45] Jennette, J. C., Falk, R. J., Andrassay, K., et al. Nomenclature of systemic vasculitides.
Proposal of an international conference. Arthritis Rheum. 1994; 37:187-192.

[46] O?Neil, K. M. Progress in pediatric vasculitis. Curr. Opin. Rheumatol. 2009; 21:538-
546.

[47] Godman, G. C., Churg, J. Wegener?s granulomatosis: pathology and review of the
literature. Arch. Pathol. 1954; 58:533-553.

[48] Guillevin, L., Visser, H., Noel, L. H., et al. Antineutrophil cytoplasm antibodies in
systemic polyarteritis nodosa with and without hepatitis B virus infection and Churg-
Strauss syndrome-62 patients. J. Rheumatol. 1993; 20:1345-1349.

[49] Fauci, A. S., Haynes, B. F., Katz, P., et al. Wegener?s granulomatosis: Prospective
clinical and therapeutic experience with 85 patients over 21 years. Ann. Intern. Med.
1983; 98:76-85.

[50] Hoffman, G. S., Kerr, G. S., Leavitt, R. Y., et al. Wegener granulomatosis: an analysis
of 158 patients. Ann. Intern. Med. 1992; 116:488-498.

[51] Carrington, C. B., Libow, A. A. Limited forms of angiitis and granulomatosis of
Wegener?s type. Am. J. Med. 1966; 41:497-527.

[52] Holle, J. U., Gross, W. L., Hull-Ulrich, K., et al. Prospective long-term followup of
patients with localized Wegener?s granulomatosis: does it occur as persistent disease
stage? Ann. Rheum. Dis. 2010; 69:1934-1939.

[53] Leavitt, R. Y., Fauci, A. S., Bloch, D. A., et al. The American College of
Rheumatology 1990 criteria for the classification of Wegener?s granulomatosis.
Arthritis Rheum. 1990; 33:1101-1107.

[54] Holle, J. U., Csernok, E., Fredenhagen, G., et al. Clinical evaluation of hsPR3-ANCA
ELISA for detection of antineutrophil cytoplasmic antibodies directed against PR3.
Ann. Rheum. Dis. 2010; 69:468-469.

[55] Van der Woude, F. J., Rasmussen, N., Lobatto, S., et al. Autoantibodies against
neutrophils and monocytes: tool for diagnosis and marker of disease activity in
Wegener?s granulomatosis. Lancet 1985; 1:425-429.

[56] Falk, R. J., Jennette, J. C. Anti-neutrophil cytoplasmic autoantibodies with specificity
for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and
crescentic glomerulonephritis. N. Engl. J. Med. 1988; 318:1651-1657.

[57] Goldschmeding, R., Cohen Tervaert, J. W., van der Schoot, C. E., et al. Autoantibodies
against myeloid lysosomal enzymes: a novel class of autoantibodies associated with
vasculitic syndrome [Abstract]. Kidney Int. 1988; 34:558-559.

[58] Gadola, S. D., Gross, W. L. The renaissance of granulomatous inflammation in AAV.
Nat. Rev. Rheumatol. 2012; 8:74-76.

[59] Lionaki, S., Blyth, E. R., Hogan, S. L., et al. Classification of anti-neutrophil
cytoplasmic autoantibody vasculitides: the role of anti-neutrophil cytoplasmic

Complimentary Contributor Copy